CHCS April 2, 2025
In the U.S., diabetes affects more than 38 million people and accounts for one in four health care dollars spent. Medicaid beneficiaries with diabetes, in particular, experience worse glycemic control, more complications, and greater barriers to care compared to those with private insurance. Innovations in health technology, such as continuous glucose monitors (CGMs), offer powerful solutions to close these gaps, improve health outcomes, and lower costs.
CGMs are wearable devices that provide real-time tracking of blood glucose levels, enabling individuals with diabetes to make informed decisions about their care. These devices have been shown to improve glycemic control, reduce the risk of severe hypoglycemia, and enhance overall quality of life. Yet, despite their proven benefits, many Medicaid beneficiaries lack access...
Today's Sponsors
Today's Sponsor